Background. Increased arterial stiffness (AS) is a major determinant of cardiovascular complications in end-stage renal disease (ESRD) patients. Little is known about AS evolution after kidney transplantation. The aim of the study was to characterize the evolution of AS after kidney transplantation in a population of ESRD patients, in comparison to those remaining in dialysis. Methods. Eighty-eight patients (age between 35 and 65) were recruited from the waiting list for kidney transplantation of the University Hospital of Nancy. Two vascular evaluations were performed at a 1-year interval. During this interval, 39 patients were transplanted and 49 remained in dialysis. Results. At inclusion, median pulse-wave velocity (PWV) was similar in transplanted patients and transplantationpending patients, respectively, 9.2 (7.9-11.9) and 9.8 (7.7-12.1) m/s. No difference between the two groups was found at the 1-year interval. Median of time after transplantation was 6.3 (3.8-10.1) months. Median of blood pressure (MBP) decreased only in the transplanted patients [99 (93-112) versus 96 (90-101) mmHg, P < 0.01] Multivariate analysis showed that PWV changes depend on changes in MBP and baseline PWV. Conclusion. Although no difference in the 1-year PWV evolution was found, the low MBP value in transplanted patients allow to expect a better long-term evolution of AS and a better cardiovascular prognosis after kidney transplantation than in transplantation-pending patients.
Introduction
Cardiovascular diseases are the leading cause of mortality in patients with end-stage renal disease (ESRD) [1] [2] [3] . The histological study of arterial vessels in these patients reveals a process of arterial remodelling, characterized by atherosclerotic and arteriosclerotic [4] [5] [6] [7] [8] lesions. This in turn leads to increased arterial stiffness (AS), an independent factor of mortality in the ESRD population [9] . Measuring the aorto-femoral pulse-wave velocity (PWV) is a reliable means of determining AS [10, 11] .
From an epidemiological standpoint, cardiovascular prognosis is improved in dialysis patients who undergo kidney transplantation [12, 13] . This improvement appears to be related to an aggregate of factors, including significant improvement in glomerular filtration rate (GFR) with increased elimination of uraemic toxins [14] and a better control of cardiovascular risk factors [15] . The evolution of AS following renal transplantation is poorly understood. However, some authors have noted an improvement in AS after kidney transplantation [16] [17] [18] , while others have observed a stable aorto-femoral PWV with no improvement [19] .
All existing studies except for one are cross-sectional studies. The aim of the present study was to characterize the evolution of AS after kidney transplantation in a population of ESRD patients, in comparison to those patients remaining on dialysis.
Patients and methods

Patients
The TRANSARTE study (Transplantation and Arteries) is a prospective monocentric study. One hundred ESRD patients were recruited from the kidney transplant waiting list of the Transplant Department of Nancy University Hospital (Figure 1 ). Inclusion criteria were the following: age between 35 and 65, ESRD (GFR <15 mL/min/1.73m 2 ) and candidates for a first kidney transplant. Patients with a history of prior kidney transplant as well as candidates for a kidney-pancreas transplant were excluded from the study. Approval for the study was obtained from the local research ethics committee, and written informed consent was obtained for each participant.
ESRD was due to polycystic kidney disease (n ¼ 25), glomerulopathy (n ¼ 23), diabetic nephropathy (n ¼ 11), vascular nephropathy (n ¼ 10), malformative uropathy (n ¼ 10) or non-labelled (n ¼ 21). All patients were in ESRD. Seventy-eight were on dialysis at enrolment, including 64 by haemodialysis and 14 by peritoneal dialysis. Twenty-two patients were not yet dialysed.
The initial design was comprised of two vascular evaluations at a 1-year interval (Figure 1 ). The first visit with vascular examinations took place during inclusion between January and August 2007 and the second visit between January and October 2008. The chance to receive a kidney allograft was dependent on the patient selection process, regardless of disease severity, patient status or investigators' choices. Vascular examinations included repeated measurements of arterial blood pressure, repeated measurements of AS by the PulsePenÒ method as well as intimamedia thickness. We observed a minimum delay of 3 months between the date of transplantation and the second vascular measures to avoid acute rejection.
Among the 100 patients included at first visit, 3 died (2 after transplantation), 5 were lost to follow-up and 4 were excluded for unexpected events (3 cancers, 1 acute myocardial infarction). In these 12 patients, 2 were not yet dialysed. Eighty-eight remained for the second visit. During the 1-year interval between the two visits, 39 patients were transplanted and 49 had a transplantation pending. Of the 39 transplanted patients, 8 (20.5%) were not dialysed before. Of the 49 patients in the transplantation-pending group, 12 (24.5%) were not yet dialysed. Median of time elapsed between transplantation and the second visit was 6.3 (3.8-10.1) months in the transplanted group and was defined as post-transplantation exposure time.
Immunosuppression consisted of a calcineurin inhibitor, mycophenolic acid and corticosteroids, with a progressive decrease to a dose of 5 mg/day. An acute rejection was diagnosed in 12 patients and was treated medically. None of them needed acute dialysis or transplantectomy.
At inclusion, we collected for each patient data concerning antihypertensive treatment.
In the transplanted group, we collected data concerning immunosuppressive and antihypertensive treatments.
Vascular parameters
Measurements were obtained in a temperature-controlled (20°C) room, during the 24 h prior to haemodialysis. Blood pressure was measured thrice after 10 min of rest, with an automatic sphygmomanometer (DinamapÒ, Critikon). Pulse pressure was measured as systolic blood pressurediastolic blood pressure (SBP-DBP). Validations of these methods and its reproducibility have been reported previously [20] . PWV and augmentation index. PWV was determined by the foot-to-foot method, with the PulsePenÒ method [11] . Applanation tonometry was used with a simultaneously recording electrocardiogram. Carotid and femoral pulse waveforms were successively obtained with the tonometer. The time delay, which represents the difference between the R-wave and the foot of the pressure pulse waveform at each site, was computed by the PulsePenÒ and used in the calculation of PWV [PWV: distance between the heart and femoral artery (as described above), divided by the time delay], as previously validated [11] .
The carotid pressure wave was secondly analysed to identify incident and reflected waves, as well as the merging point (defined as the inflection point). The first and second systolic peaks (P1 and P2) of the derived aortic pressure waveform were also recorded. Augmented pressure was calculated as the difference between the second and the first systolic peaks (P2 À P1). The aortic augmentation index (AIx) was defined as augmented pressure expressed as a percentage of aortic pulse pressure (PP) [11] . The Aix value was not adjusted to heart rate. Carotid artery geometry. In a first step, carotid echography was used to identify and measure atherosclerotic plaques. Internal carotid diameter and carotid intima-media thickness were measured with a high-resolution B-mode (7.5 MHz transducer) echo-tracking system (Wall-Track System; PIE Medical, Maastricht, The Netherlands), as previously described, in areas free of plaques [21] . Briefly, vessel walls were identified automatically and their displacement tracked throughout the cardiac cycle. According to phase and amplitude, the radiofrequency signal during six cardiac cycles was digitized and stored until analysis. The accuracy of the system was AE30 lm for diastolic diameter and AE1 lm for stroke-diameter change. Radiofrequency matrices were acquired during 2-4 s, and acquisitions were repeated every 10 s. One patient period corresponded to 450 radiofrequency acquisitions (500-700 MB). Carotid pulse pressure (DP) was not assessed simultaneously but just immediately before measuring changes in carotid diameter. Carotid distensibility was determined from changes in pulse pressure and from systolic-diastolic changes in carotid
. Carotid compliance was determined from systolic-diastolic changes in carotid internal diameter and from changes in pulse pressure [carotid compliance ¼ (Ds À Dd)/DP (kPa À1 3 10
À3
) [21] .
Biological samples
Serum haemoglobin, glycaemia, serum creatinine, serum calcium, phosphorus and C-reactive protein were analysed at entry and after 1 year. GFR was assessed using MDRD formula [22] .
Statistical analysis
All analyses were performed using SAS software R9.1.3 (SAS Institute, Cary, NC). The two-tailed significance level was set to P <0.05. Two groups were constituted retrospectively, according to whether or not the patient had undergone kidney transplantation between the first and second visit. In the first instance, we checked whether transplanted patients were comparable with transplantation-pending control patients at first visit and then studied differences between transplanted and transplantationpending patients at the second visit. Results are described as frequencies (percent) for categorical variables and as medians inter quartile range (IQR) for continuous variables. The two groups were compared using chi-square test (or Fisher's exact test when required) and Mann-Whitney's test. The change from baseline inside each group was analysed using the McNemar test and paired Wilcoxon test.
The association between PWV change from baseline and patient characteristics was analysed using multivariate mixed analysis of variance, with transplantation, baseline PWV, median of blood pressure (MBP) change from baseline, age and gender as fixed effects and patients as random effect. Dialysis duration was added to these covariates in the multivariate model for all dialysed patients at inclusion. Post-transplantation exposition time was added in the transplanted group analysis. These factors were chosen on a pathophysiological basis in accordance with the literature data. The validity of the models was systematically assessed.
Results
Characteristics of each group are described in Table 1 . There was no significant difference in terms of age, BMI, sex, past history of hypertension or diabetes, with the exception of smoking. There was no statistical difference between two groups in terms of dialysis duration [19 (12-33 ) versus 15 (6-26) months, P ¼ 0.12) in transplantation and transplantation-pending groups, respectively. Median values were 12.2 (11.3-13.0) g/dL for serum haemoglobin, 9.1 (8.7-9.6) mg/dl for serum calcium and 5.3 (4.3-6.4) mg/dl for serum phosphorus. In the subgroup of diabetic patients (n ¼ 9), median glycaemia was 1.4 (1.25-2.27) g/L. Vascular characteristics of the population at inclusion are shown in Table 2 . Both groups were comparable for all vascular parameters studied during the first visit. On the second visit, median of serum creatinine in the transplanted patients group was 1.4 (1.2-1.6) mg/dL, representing a median of GFR of 49 (42-54) mL/min/1.73m 2 . Median of serum calcium was significantly higher among transplanted patients comparatively to dialysis patient groups [10.2 (9.8-10.6) versus 9.0 (8.6-9.6) mg/dL, Table 2 presents the vascular parameters of the study population on the second visit. No significant differences were observed between the two groups. Concerning intimamedia thickness (IMT), arterial distensibility and arterial compliance, we studied in each group changes from baseline and did not find any significant difference. In the transplanted group, 22 patients received an immunosuppression by cyclosporine, 11 by tacrolimus and 6 by other. We did not find any difference in terms of vascular parameters between the cyclosporine and tacrolimus subgroups. Table 3 illustrates the predictive factors of PWV development in the overall population and in dialysed patients group at inclusion. The PWV change was significantly and negatively associated with baseline PWV at inclusion in both overall population and the dialysed patients group (slope ¼ À0.36, P < 0.001; slope ¼ À0.28, P < 0.001, respectively) as well as positively with the decrease in mean arterial pressure (MAP) (slope ¼ 0.05, P < 0.01; slope ¼ 0.05, P ¼ <0.01, respectively). PWV did not appear to be predicted by age or the fact of having received a transplant. In the dialysed patients group, PWV was not predicted by dialysis duration (slope ¼ 0.01, P ¼ 0.63). Table 4 illustrates the predictive factors of PWV development in the transplanted group. The change in PWV was seemingly predicted by both baseline PWV (slope ¼ À0.49, P < 0.001) and changes in MAP (slope ¼ 0.07, P < 0.05). This relationship remained present after adjustment of GFR and donor age. PWV evolution was not Pulse-wave analysis (PulsePen) Pulse-wave velocity (m/s) 9.6 (7.9-11.9) 9.2 (7.9-11.9) 9.8 (7.7-12.1) 0.67 9.9 (7.9-11.5) 9.3 (7. predicted by the interval of time elapsed following kidney transplantation nor by the age of the recipient.
Discussion
While the evolution of AS in ESRD dialysis patients is now well known, there is little data, however, as to the fate of these parameters after kidney transplantation. To our knowledge, this is the first study that compared evolution of AS in two groups of patients, one remaining in chronic renal failure or in dialysis and the second with patients being transplanted. The fact that patients underwent transplantation was not dependent on randomization criteria (unethical in this context), but based on the criteria governing the allocation of grafts in the absence of an urgent context for transplantation. Our population nonetheless remained homogeneous, a finding that was confirmed by the comparability of the two groups at inclusion. However, there is a selection bias in this population: we chose to include patients from the transplant waiting list, namely ESRD patients capable of supporting a kidney transplant (30% of dialysis patients in France and 20% of dialysis patients in the Lorraine region) [23] . Inclusion age was limited to between 35 and 65 years of age in order to exclude older recipients and render the study population as homogeneous as possible. The allocation of a graft for each patient was conducted in accordance with standard procedures in effect in France (randomization being impossible in this context).
Mean PWV values measured at inclusion were comparable to those described in a population of apparently healthy subjects with a mean age between 70 and 75 years [24] , thus indicating an accelerated arterial aging in the ESRD population. To our knowledge, this study is also the first to use the PulsePen method in this population.
The data herein did highlight a significant decrease in peripheral DBP and MBP after kidney transplantation, as previously reported in the literature [25] . Indeed, Bahous et al. identified a decrease in MBP after kidney transplantation when compared with dialysed control subjects. In the present study, we were unable to differentiate between a reduction in pressures secondary to the effect of antihypertensive treatment or due to kidney transplantation as such.
Our results did not reveal a significant reduction in central PWV after kidney transplantation. Such results have already been described in previous studies conducted without a control group [19] . In a cohort of 36 transplanted patients, Zoungas et al. did not observe any significant reduction in aorto-femoral PWV after 1 year but did observe a decrease in peripheral PWV (femoro-pedial). In the study of De Lima et al. [16] , in a cohort of 32 patients followed for an average of 40 months post-transplantation, there were improved indirect markers of AS (left ventricular hypertrophy, carotid distensibility) after 40 months as well as a normalization of carotid intima-media thickness. However, PWV was not assessed in this latter study. The above markers of AS are reliable albeit indirect in comparison to PWV. There are currently no studies demonstrating a significant decrease in PWV after >1 year post-kidney transplantation. Globally, it is estimated that over a period of 1 year, in the general population, PWV is expected to increasẽ 0.1 m/s/year. In ESRD patients, this increase is estimated at~0.2 to 0.3 m/s/year, in the absence of intervention. In the present study, there was no significant change in PWV in either transplanted or transplantation-pending patients after 1 year of monitoring. Follow-up and post-transplant exposure time was short, however, such that arterial structural changes are very unlikely to occur and be observed clinically in such a short time frame. Longer term follow-up monitoring would allow for better characterization of the evolution of PWV. Given that in multivariate analysis, the change in PWV was dependent on the decrease in MBP and that this modification in PWV was greater in transplanted patients, the effect on PWV might be greater in those transplanted over a longer period of time.
In addition, upon multivariate analysis, the PWV change was significantly and negatively associated with baseline PWV at inclusion as well as positively with the decrease in MBP, an observation already described in the literature. In the overall cohort on the other hand, the evolution of PWV was not found to be associated with patient age, contrary to other populations [24] . This could be explained by the effect of ESRD on AS, an effect which is much more important than age in this particular population.
In the transplanted group, we observed the same relationship between PWV change and baseline PWV and MBP, as well as in the global model after adjustment for donor age, thus illustrating the known link between arterial blood pressure and PWV. Contrary to the study of Delahousse et al., we did not observe any association between post-graft PWV and donor age even though donor ages were comparable in the two studies (17-70 years in the Delahousse study and 18-75 years in our cohort) [26] . However, the number of subjects in our transplanted group was lower than in the study of Delahousse et al.
We did not find any significant relationship between post-transplantation GFR (MDRD formula) and PWV, neither in the global model nor after adjustment for donor age. In the literature, Kneifel et al. had identified a link between a single post-transplantation measurement of PWV and GFR in 48 transplanted subjects after a mean of 17 AE 1 months [27] . In the study herein, post-transplant exposure time was shorter, which could explain the absence of correlation between GFR and PWV in our model. This present study does carry certain limitations: the number of patients is small with a short follow-up period, as well as a short post-graft exposure time. This choice was justified by our desire to maintain a relatively large number in our control group. The failure to identify a difference in PWV between the groups may also be confounded by a limited duration of an effect of transplantation or other related factors (e.g. calcineurin blockade, decreased EPO use, serum uric acid, parathormon, lipid levels). Concerning vascular parameters, carotid compliance was not measured simultaneously with carotid pulse pressure, but just after.
Conclusions
The present study is the first to be conducted in a setting aimed at assessing the effect of kidney transplantation on the evolution of AS in a patient population with ESRD. Results suppose a significant association in peripheral diastolic blood pressure and mean arterial pressure in transplanted patients. The evolution of PWV is dependent on the decrease in MBP as well as on initial baseline PWV. Hence, while we do not observe a direct link between PWV modification and kidney grafting in patients, there is nevertheless an indirect association between this decrease in PWV and transplantation. All these factors might explain the improved cardiovascular prognosis of dialysis patients undergoing kidney transplantation.
